No connection

Search Results

KVYO

NEUTRAL
$19.94 Live
Klaviyo, Inc. · NYSE
Target $32.9 (+65.0%)
$15.53 52W Range $37.79

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 29, 2026
Market cap
$6.08B
P/E
N/A
ROE
-2.8%
Profit margin
-2.6%
Debt/Equity
0.1
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
80%
KVYO presents a stark contrast between strong fundamental growth and bearish market sentiment. The Piotroski F-Score of 5/9 indicates stable financial health, supported by a very strong current ratio (4.27) and minimal debt (D/E 0.10). While revenue growth remains robust at 29.6% and EPS growth is explosive (+171.4%), the stock is plagued by a severe technical downtrend and aggressive insider selling by the CEO. The valuation appears attractive on a forward P/E basis (19.89), but the lack of current profitability and negative price momentum offset the bullish analyst consensus.

Key Strengths

Strong revenue growth of 29.6% YoY
Exceptional liquidity with a current ratio of 4.27
High gross margins (74.67%) indicating strong pricing power
Consistent earnings beats with high average surprises (21.9%)
Very low leverage with a Debt/Equity ratio of 0.10

Key Risks

Aggressive insider selling, specifically by the CEO
Negative net profit margin (-2.57%)
Severe technical breakdown (1Y change of -34.3%)
High Price/Book ratio (5.07) relative to current profitability
Dependence on high-growth expectations to justify valuation
AI Fair Value Estimate
Based on comprehensive analysis
$26.42
+32.5% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
50
Moderate
Value
65
Future
85
Past
30
Health
70
Dividend
0
AI Verdict
Fundamental Growth vs. Market Skepticism
Key drivers: Revenue Growth, Balance Sheet Liquidity, Insider Selling, Technical Trend
Confidence
85%
Value
65/100

Forward P/E suggests value, but Graham Number is N/A due to lack of positive earnings.

Positives
  • Forward P/E of 19.89 is reasonable for software growth
Watchpoints
  • P/S of 4.92 is moderate
  • Negative current earnings
Future
85/100

Growth metrics are the primary bullish driver.

Positives
  • 29.6% YoY Revenue growth
  • 171.4% YoY EPS growth
  • Strong analyst target price of $32.90
Watchpoints
  • Market not yet pricing in growth
Past
30/100

Historical price performance is overwhelmingly bearish.

Positives
  • Consistent earnings beats
Watchpoints
  • 1Y return of -34.3%
  • 6M return of -22.7%
Health
70/100

Strong balance sheet offsets current lack of profitability.

Positives
  • Piotroski F-Score 5/9 (Stable)
  • Low Debt/Equity (0.10)
  • High Quick Ratio (3.99)
Watchpoints
  • Negative ROE and ROA
Dividend
0/100

Typical for high-growth software companies.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$19.94
Analyst Target
$32.9
Upside/Downside
+65.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for KVYO and closest competitors.

Updated 2026-04-28
KVY
Klaviyo, Inc.
Primary
5Y
-39.1%
3Y
-39.1%
1Y
-34.3%
6M
-22.7%
1M
+5.1%
1W
-1.8%
ARW
Arrow Electronics, Inc.
Peer
5Y
+11.2%
3Y
+0.7%
1Y
-2.2%
6M
-8.7%
1M
+3.7%
1W
-1.3%
NIC
NICE Ltd.
Peer
5Y
-57.4%
3Y
-55.5%
1Y
-33.7%
6M
-23.0%
1M
-14.1%
1W
-9.5%
APP
AppFolio, Inc.
Peer
5Y
+21.3%
3Y
+44.8%
1Y
-16.5%
6M
-37.5%
1M
-3.5%
1W
-9.8%
DBX
Dropbox, Inc.
Peer
5Y
-14.8%
3Y
+11.9%
1Y
-7.3%
6M
-18.9%
1M
-11.7%
1W
+3.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
19.89
PEG Ratio
N/A
P/B Ratio
5.07
P/S Ratio
4.92
EV/Revenue
4.16
EV/EBITDA
-94.3
Market Cap
$6.08B

Profitability

Profit margins and return metrics

Profit Margin -2.57%
Operating Margin -0.52%
Gross Margin 74.67%
ROE -2.85%
ROA -2.78%

Growth

Revenue and earnings growth rates

Revenue Growth +29.6%
Earnings Growth N/A
Q/Q Revenue Growth +29.62%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.1
Low debt
Current Ratio
4.27
Strong
Quick Ratio
3.99
Excellent
Cash/Share
$3.49

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.4B
Gross Margin
72.2%
Op. Margin
-0.5%
Net Margin
2.0%
Total Assets
$1.6B
Liabilities
$0.4B
Equity
$1.2B
Debt/Equity
0.32x
Operating CF
$0.1B
CapEx
$-0.0B
Free Cash Flow
$0.1B
FCF Yield
94%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-02-10
$0.19
+10.3% surprise
2025-11-05
$0.18
+29.4% surprise
2025-08-05
$0.16
+26.1% surprise

Technology Sector Comparison

Comparing KVYO against 585 companies in the Technology sector (44 bullish, 210 neutral, 331 bearish)
Return on Equity (ROE)
-2.85%
This Stock
vs
-32.34%
Sector Avg
-91.2% (Below Avg)
Profit Margin
-2.57%
This Stock
vs
-11.65%
Sector Avg
-77.9% (Weaker)
Debt to Equity
0.1
This Stock
vs
0.76
Sector Avg
-86.7% (Less Debt)
Revenue Growth
29.6%
This Stock
vs
4230.22%
Sector Avg
-99.3% (Slower)
Current Ratio
4.27
This Stock
vs
3.68
Sector Avg
+16.2% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

EDMOND LANDON RAMON
Officer
Sell
2026-04-20
9,623 shares · $192,460
WHALEN AMANDA
Chief Financial Officer
Sell
2026-04-16
14,000 shares · $259,560
WHALEN AMANDA
Chief Financial Officer
Stock Award
2026-04-16
4,293 shares
WHALEN AMANDA
Chief Financial Officer
Stock Award
2026-04-15
492,423 shares
GALVIN CARMEL
Officer
Stock Award
2026-04-15
351,730 shares
EDMOND LANDON RAMON
Officer
Stock Award
2026-04-15
281,385 shares
BIALECKI ANDREW
Chief Executive Officer
Sell
2026-04-14
200,000 shares · $3,437,114
BIALECKI ANDREW
Chief Executive Officer
Stock Award
2026-04-14
200,000 shares
BIALECKI ANDREW
Chief Executive Officer
Sell
2026-04-07
200,000 shares · $3,726,000
BIALECKI ANDREW
Chief Executive Officer
Stock Award
2026-04-07
200,000 shares
BIALECKI ANDREW
Chief Executive Officer
Sell
2026-03-31
200,000 shares · $3,884,000
BIALECKI ANDREW
Chief Executive Officer
Stock Award
2026-03-31
200,000 shares
BIALECKI ANDREW
Chief Executive Officer
Sell
2026-03-24
200,000 shares · $3,634,000
BIALECKI ANDREW
Chief Executive Officer
Stock Award
2026-03-24
200,000 shares
BIALECKI ANDREW
Chief Executive Officer
Sell
2026-03-17
200,000 shares · $3,873,821
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-03-02
10-K
10-K
2026-02-10

KVYO filed its annual 10-K report on February 10, 2026. Due to the absence of detailed text in the provided excerpts, specific financial highlights and risk factors cannot be determined.

8-K
8-K
2026-02-10

Karyopharm Therapeutics Inc. likely filed this 8-K to report its full-year financial results and provide corporate guidance.

8-K
8-K
2025-12-09
8-K
8-K
2025-12-02
10-Q
10-Q
2025-11-05

KVYO submitted its 10-Q filing on November 5, 2025. While the document includes a section for Risk Factors under Item 1A, specific financial highlights and risk details were not provided in the available excerpt.

8-K
8-K
2025-11-05
8-K
8-K
2025-09-25

Klaviyo, Inc. filed a current report on September 25, 2025, likely to disclose material corporate events or financial updates.

8-K
8-K
2025-08-29
8-K
8-K
2025-08-15
10-Q
10-Q
2025-08-05
8-K
8-K
2025-08-05
8-K
8-K
2025-08-05
8-K
8-K
2025-06-11
8-K
8-K
2025-05-16
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
STRONG_BUY
21 analysts
Citigroup
2026-04-28
Maintains
Buy Buy
Cantor Fitzgerald
2026-04-15
Maintains
Overweight Overweight
Macquarie
2026-02-12
Maintains
Neutral Neutral
Jefferies
2026-02-11
Maintains
Buy Buy
Citigroup
2026-02-11
Maintains
Buy Buy
Truist Securities
2026-02-11
Maintains
Buy Buy
Benchmark
2026-02-11
Maintains
Buy Buy
Stifel
2026-02-11
Maintains
Buy Buy
Wells Fargo
2026-02-11
Maintains
Overweight Overweight
Barclays
2026-02-11
Maintains
Overweight Overweight

Past News Coverage

Recent headlines mentioning KVYO from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile